NCT06943664 2026-02-18Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung CancerRoswell Park Cancer InstitutePhase 2 Not yet recruiting27 enrolled